Mayo Clinic Laboratory and Pathology Research Roundup: Jan. 1

The Research Roundup provides an overview of the past week’s research from Mayo Medical Laboratories consultants, including featured abstracts and complete list of published studies and reviews.


Featured Abstract

Multifaceted Fanconi Anemia Signaling

In 1927, Guido Fanconi described a hereditary condition presenting panmyelopathy accompanied by short stature and hyperpigmentation, now better known as Fanconi anemia. With this discovery the genetic and molecular basis underlying Fanconi anemia has emerged as a field of great interest. Fanconi anemia signaling is crucial in the DNA damage response (DDR) to mediate the repair of damaged DNA. This has attracted a diverse range of investigators, especially those interested in aging and cancer. However, recent evidence suggests Fanconi anemia signaling also regulates functions outside the DDR, with implications for many other frontiers of research. Mayo Clinic researchers discuss the characteristics of Fanconi anemia functions and expand upon current perspectives regarding the genetics of Fanconi anemia, indicating that Fanconi anemia plays a role in a myriad of molecular and cellular processes. The study was published in Trends in Genetics.


Published to PubMed This Week

kschrib

Kelley Schreiber

Kelley Schreiber is a Marketing Channel Manager at Mayo Medical Laboratories. She is the principle editor and writer of Insights and leads social media and direct marketing strategy. Kelley has worked at Mayo Clinic since 2013. Outside of work, you can find Kelley running, traveling, playing with her new kitten, and exploring new foods.